IL11RA and non-small cell lung carcinoma: We conducted a mediation analysis focusing on NCAPD2, IL11RA, and MLC1 as potential therapeutic targets for NSCLC, to further explore whether these targets mediate the impact of various smoking statuses on NSCLC.